Coronary artery disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who give a full consent to this study (2) Effort or resting angina (chest pain, documented ST-T change on electrocardiogram [ECG], or symptoms relieved by administration of nitroglycerin) (3) Asymptomatic patients with multiple coronary risk factors for CAD. (4) All patients perform ATP-stree dynamic myocardial CT perfusion and myocardial perfusion imaging (SPECT or cardiac MRI) within a month.
Exclusion criteria
Exclusion criteria: (1) acute myocardial infarction (2) cardiomyopathy (3) severe left ventricular dysfunction (ejection fraction < 20%) (4) chronic atrial fibrillation (5) greater than first degree atrio-ventricular block (6) symptomatic congestive heart failure of New York Heart Association class IV (7)percutaneous coronary intervention (8) history of coronary artery bypass graft (9) hypotension (systolic blood pressure < 90 mm Hg) (10) severe chronic obstructive pulmonary disease (11) chronic kidney disease (serum creatinine > 1.5 mg/dl) (12) pregnancy (13) known history of hyperthyroidism and bronchial asthma (14) known hypersensitivity to contrast media.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differentiation of CT-derived MBF among normal, ischemic and infarcted myocardium in patient groups of SPECT and cardiac MR, respectively. Diagnostic accuracy of CT-derived MBF for detecting myocardial perfusion abnormality on SPECT and cardiac MR. | — |
Countries
Japan
Contacts
Ehime University Graduate School of Medicine. Department of Radiology